<VariationArchive RecordType="classified" VariationID="830913" VariationName="NC_000007.14:g.(?_66081783)_(66083194_?)del" VariationType="Deletion" Accession="VCV000830913" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-03-26" DateCreated="2020-04-15" MostRecentSubmission="2023-03-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="819910" VariationID="830913">
      <GeneList>
        <Gene Symbol="ASL" FullName="argininosuccinate lyase" GeneID="435" HGNC_ID="HGNC:746" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="66075819" stop="66093576" display_start="66075819" display_stop="66093576" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="65540775" stop="65558329" display_start="65540775" display_stop="65558329" Strand="+" />
          </Location>
          <OMIM>608310</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000007.14:g.(?_66081783)_(66083194_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" innerStart="65546770" innerStop="65548181" display_start="65546770" display_stop="65548181" variantLength="1412" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.(?_65546770)_(65548181_?)del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.(?_65546770)_(65548181_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000007.14:g.(?_66081783)_(66083194_?)del AND Argininosuccinate lyase deficiency" Accession="RCV001031511" Version="2">
        <ClassifiedConditionList TraitSetID="605">
          <ClassifiedCondition DB="MedGen" ID="C0268547">Argininosuccinate lyase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-06-10" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2023-03-26">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">2263616</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24166829</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="605" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="326" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Argininosuccinic Aciduria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Arginino succinase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inborn error of urea synthesis, arginino succinic type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Urea cycle disorder, arginino succinase type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Argininosuccinate lyase deficiency</ElementValue>
                <XRef ID="Argininosuccinic+Aciduria/576" DB="Genetic Alliance" />
                <XRef ID="41013004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ASL deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ASA deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Argininosuccinate acidemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Argininosuccinic acid lyase deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Deficiency of argininosuccinate lyase (ASL), the enzyme that cleaves argininosuccinic acid to produce arginine and fumarate in the fourth step of the urea cycle, may present as a severe neonatal-onset form or a late-onset form: The severe neonatal-onset form is characterized by hyperammonemia within the first few days after birth that can manifest as increasing lethargy, somnolence, refusal to feed, vomiting, tachypnea, and respiratory alkalosis. Absence of treatment leads to worsening lethargy, seizures, coma, and even death. In contrast, the manifestations of late-onset form range from episodic hyperammonemia triggered by acute infection or stress to cognitive impairment, behavioral abnormalities, and/or learning disabilities in the absence of any documented episodes of hyperammonemia. Manifestations of ASL deficiency that appear to be unrelated to the severity or duration of hyperammonemic episodes: Neurocognitive deficiencies (attention-deficit/hyperactivity disorder, developmental delay, seizures, and learning disability). Liver disease (hepatitis, cirrhosis). Trichorrhexis nodosa (coarse brittle hair that breaks easily). Systemic hypertension.</Attribute>
                <XRef ID="NBK51784" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5843" />
                <XRef ID="5843" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21290785</ID>
                <ID Source="BookShelf">NBK51784</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301396</ID>
                <ID Source="BookShelf">NBK1217</ID>
              </Citation>
              <Citation Type="Position Statement" Abbrev="HGS Australasia, 2019">
                <URL>https://www.hgsa.org.au/documents/item/8694</URL>
                <CitationText>Policy: Recommendations for Screening for Specific Disorders</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, ACT Sheet, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Citrullinemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, [Elevated Citrulline], Amino Acidemia/Urea Cycle Disorder, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Citrulline-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Elevated Citrulline: Amino Acidemia Algorithm, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Argininosuccinic-Acidemia-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Argininosuccinic Acidemia, [Urea Cycle Disorder], 2012</CitationText>
              </Citation>
              <XRef ID="23" DB="Orphanet" />
              <XRef ID="C0268547" DB="MedGen" />
              <XRef ID="MONDO:0008815" DB="MONDO" />
              <XRef Type="MIM" ID="207900" DB="OMIM" />
              <XRef Type="primary" ID="HP:0025630" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2356071" SubmissionDate="2023-03-21" DateLastUpdated="2023-03-26" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="NM_000048.3_Deletion (Exons 3-6)|MedGen:C0268547" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194817" DateUpdated="2023-03-26" DateCreated="2020-04-15" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">2263616</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24166829</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24166829</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 3-6 of the ASL gene. This deletion is out-of-frame, and is expected to create a premature termination codon and result in an absent or disrupted protein product. Loss-of-function variants in ASL are known to be pathogenic (PMID: 2263616, 24166829). A similar copy number variant has been observed in individual(s) with argininosuccinate lyase deficiency (PMID: 24166829). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.(?_65546770)_(65548181_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268547" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12974844</SubmissionName>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2356071" TraitType="Disease" MappingType="XRef" MappingValue="C0268547" MappingRef="MedGen">
        <MedGen CUI="C0268547" Name="Argininosuccinate lyase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

